| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/21/2002 | WO2002022166A2 Tweak receptor agonists as anti-angiogenic agents |
| 03/21/2002 | WO2002022164A1 Composition comprising immunogenic microparticles |
| 03/21/2002 | WO2002022161A2 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 03/21/2002 | WO2002022160A2 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 03/21/2002 | WO2002022159A1 Thionin as an antineoplastic and immunostimulant |
| 03/21/2002 | WO2002022155A1 Immunogenic composition of hepatitis c and methods of use thereof |
| 03/21/2002 | WO2002022149A1 Use of il-6r/il-6 chimera in huntington's disease |
| 03/21/2002 | WO2002022080A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | WO2002022077A2 Compositions and methods for inhibition of hiv-1 infection |
| 03/21/2002 | WO2002021996A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | WO2001096388A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/21/2002 | WO2001096380A8 IMMUNIZATION OF DAIRY CATTLE WITH Mig PROTEIN |
| 03/21/2002 | WO2001094419A3 Method to induce the th1 immune response |
| 03/21/2002 | WO2001082962A3 Immunizing against hiv infection |
| 03/21/2002 | WO2001078650A3 Vaccines for protection against borrelia burgdorferi |
| 03/21/2002 | WO2001074847A3 T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer |
| 03/21/2002 | WO2001068859A3 Il-17 receptor like molecules and uses thereof |
| 03/21/2002 | WO2001064252A3 Farnesyl protein transferase inhibitor combinations with further anti-cancer agents |
| 03/21/2002 | WO2001060402A3 Proteosome influenza vaccine |
| 03/21/2002 | WO2001058954A3 Trade molecules and uses related thereto |
| 03/21/2002 | WO2001051513A3 Ovarian tumor-associated sequences |
| 03/21/2002 | WO2001049775A3 Antisense antibacterial cell division composition and method |
| 03/21/2002 | WO2001045670A3 A stable immunogenic composition for frozen storage |
| 03/21/2002 | WO2001042295A3 Clasp-7 transmembrane protein |
| 03/21/2002 | WO2001041797A3 Systemic immune response induced by mucosal administration of l ipid-tailed polypeptides without adjuvant |
| 03/21/2002 | WO2001040465A3 Compositions and methods for the treatment of immune related diseases |
| 03/21/2002 | WO2001037779A3 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 03/21/2002 | WO2001034187A3 Preparation and method for prevention of coccidiosis |
| 03/21/2002 | WO2001031009A3 Chandra: a th1-specific gene |
| 03/21/2002 | WO2001030375A3 Use of gdnf for treating corneal defects |
| 03/21/2002 | US20020035118 Low molecular weight cell, bone marrow and immune stimulants |
| 03/21/2002 | US20020035080 Proliferation potential proteins (P2P), involved in RNA processing; repressing the proliferative potential of a cell with an antisense oligonucleotide that binds to a domain of the open reading frame of P2P cDNA |
| 03/21/2002 | US20020035075 Methods and compositions for treating inflammatory bowel disease |
| 03/21/2002 | US20020034786 Nucleotide sequences coding G protein coupled receptor; for use in the diagnosis and treatment of defects in signal transduction |
| 03/21/2002 | US20020034779 Novel argS |
| 03/21/2002 | US20020034768 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 03/21/2002 | US20020034758 Novel human genes and gene expressions products: II |
| 03/21/2002 | US20020034751 Aspergillus fumigatus antigenic protein 1 |
| 03/21/2002 | US20020034749 Reagents and methods useful for detecting diseases of the breast |
| 03/21/2002 | US20020034736 Nucleotide sequences coding modulators for use in therapy against tumors, retinopathy, perfusion injuries, fibrosis, artherosclerosis, angiogenesis, inflammation, and restenosis; antiischemic and antitumor agents |
| 03/21/2002 | US20020034734 Vaccine composition for preventing or treating hepatitis C |
| 03/21/2002 | US20020034724 Methods to selectively inactivate microorganisms in biological compositions |
| 03/21/2002 | US20020034551 Method of making microencapsulated DNA for vaccination and gene therapy |
| 03/21/2002 | US20020034523 Immunogenic preparation and method for improving the productivity of ruminant animals |
| 03/21/2002 | US20020034522 Use of a strain of pasteurella haemolytica of a particular serotype for preparing a vaccine against bovine pasteurellosis due to pasteurella haemolytica |
| 03/21/2002 | US20020034520 Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases |
| 03/21/2002 | US20020034519 Modified bovine adenovirus having altered tropism |
| 03/21/2002 | US20020034518 Vaccines |
| 03/21/2002 | US20020034517 Dendritic cell stimulatory factor |
| 03/21/2002 | US20020034515 Proteus mirabilis-based vaccine |
| 03/21/2002 | US20020034514 Administering microsphere of immunogens; enteric overcoatings |
| 03/21/2002 | US20020034513 MHC complexes and uses thereof |
| 03/21/2002 | US20020034509 Methods and compositions for ameliorating the symptoms of sepsis |
| 03/21/2002 | US20020034508 Binding antibody to epitopes |
| 03/21/2002 | US20020034505 Genetic enginnering; kits |
| 03/21/2002 | US20020034504 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 03/21/2002 | US20020034494 Fusion protein of chemokine and antigens |
| 03/21/2002 | DE10138935A1 Synthetische Verbindungen vom Nicht-Mucintyp oder ihre mit einem Träger konjugierten Verbindungen Synthetic compounds from non-mucin or its conjugated with a carrier compounds |
| 03/21/2002 | DE10044648A1 Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material Method of replication or removal of Cirocoviren from biological material |
| 03/21/2002 | CA2422882A1 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | CA2422828A1 Novel tumor-associated marker |
| 03/21/2002 | CA2422603A1 Vectors for molecule delivery to cd11b expressing cells |
| 03/21/2002 | CA2422586A1 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | CA2422575A1 Composition comprising immunogenic microparticles |
| 03/21/2002 | CA2422454A1 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | CA2422278A1 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | CA2422275A1 Compositions and methods for inhibition of hiv-1 infection |
| 03/21/2002 | CA2422229A1 Calcium binding proteins |
| 03/21/2002 | CA2422163A1 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | CA2422095A1 Tweak receptor agonists as anti-angiogenic agents |
| 03/21/2002 | CA2422076A1 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 03/21/2002 | CA2422068A1 Method for treatment of insulin resistance in obesity and diabetes |
| 03/21/2002 | CA2422032A1 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 03/21/2002 | CA2422002A1 Vaccine |
| 03/21/2002 | CA2421998A1 Vaccine against streptococcus pneumoniae |
| 03/21/2002 | CA2421994A1 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 03/21/2002 | CA2421952A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | CA2421751A1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 03/21/2002 | CA2421234A1 Interferon-alpha induced gene |
| 03/21/2002 | CA2420459A1 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | CA2391407A1 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/20/2002 | EP1188834A1 Recombinant MVA expressing the HER-2/neu gene |
| 03/20/2002 | EP1188832A1 A delivery method for the tumor specific apoptosis inducing activity of apoptin |
| 03/20/2002 | EP1188766A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 03/20/2002 | EP1188446A1 Proteinaceous vectors for molecule delivery to CD11b expressing cells |
| 03/20/2002 | EP1187931A1 49 human secreted proteins |
| 03/20/2002 | EP1187927A2 Hcv/bvdv chimeric genomes and uses thereof |
| 03/20/2002 | EP1187918A1 Tek antagonists |
| 03/20/2002 | EP1187916A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/20/2002 | EP1187915A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 03/20/2002 | EP1187911A2 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
| 03/20/2002 | EP1187908A1 42 human secreted proteins |
| 03/20/2002 | EP1187907A1 Method for the preservation of biologically-active material |
| 03/20/2002 | EP1187842A1 Human tumor necrosis factor receptor tr10 |
| 03/20/2002 | EP1187637A2 Alpha or beta emitters attached to fragments in radioimmunotherapy |
| 03/20/2002 | EP1187634A1 Cell growth inhibition |
| 03/20/2002 | EP1187632A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 03/20/2002 | EP1187631A1 Prevention of type 1 diabetes and other non-polio enterovirus diseases |
| 03/20/2002 | EP1187630A1 Rapid immunoassay to detect antibodies in saliva to disease-related microorganisms antigens |
| 03/20/2002 | EP1187629A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |